| Display title | A Local Authority v A [2020] EWCOP 76 |
| Default sort key | A Local Authority v A (2020) EWCOP 76 |
| Page length (in bytes) | 1,376 |
| Page ID | 14998 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| Edit | Allow only users with "editing" permission (infinite) |
| Move | Allow only users with "editing" permission (infinite) |
| Page creator | Jonathan (talk | contribs) |
| Date of page creation | 21:11, 24 March 2023 |
| Latest editor | Jonathan (talk | contribs) |
| Date of latest edit | 08:50, 14 September 2023 |
| Total number of edits | 6 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | This application was to consider the administration to A of covert medication in relation to primary ovarian failure. (1) It was permissible and proportionate for A's mother not to be informed of the proceedings because she would seek to subvert the medical treatment. (2) The advantages (to achieve adulthood via puberty, the possibility of developing her own family, cognitive development and maturity, proportionate independence and personal autonomy, a hundred percent effectiveness, no associated risk, a normal life expectancy, no death by a serious fracture or cardiovascular disease by 30 to 40 years of age, and the fact that covert administration is the least restrictive approach pursuant to the MCA 2005) outweighed the disadvantages (it was against A's current wishes, if A discovered that she had been covertly medicated she might lose trust or confidence with the placement) and it was in A's best interests to receive the treatment. |